Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Chemours (CC) EBITDA (2016 - 2025)

Historic EBITDA for Chemours (CC) over the last 12 years, with Q3 2025 value amounting to $94.0 million.

  • Chemours' EBITDA rose 39473.68% to $94.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year decrease of 9881.42%. This contributed to the annual value of $27.0 million for FY2024, which is 14029.85% up from last year.
  • According to the latest figures from Q3 2025, Chemours' EBITDA is $94.0 million, which was up 39473.68% from -$205.0 million recorded in Q2 2025.
  • Chemours' EBITDA's 5-year high stood at $304.0 million during Q1 2022, with a 5-year trough of -$396.0 million in Q2 2023.
  • In the last 5 years, Chemours' EBITDA had a median value of $94.0 million in 2025 and averaged $77.1 million.
  • In the last 5 years, Chemours' EBITDA plummeted by 28248.85% in 2023 and then skyrocketed by 111666.67% in 2024.
  • Over the past 5 years, Chemours' EBITDA (Quarter) stood at $203.0 million in 2021, then plummeted by 104.43% to -$9.0 million in 2022, then surged by 33.33% to -$6.0 million in 2023, then surged by 1116.67% to $61.0 million in 2024, then surged by 54.1% to $94.0 million in 2025.
  • Its EBITDA stands at $94.0 million for Q3 2025, versus -$205.0 million for Q2 2025 and $53.0 million for Q1 2025.